# Hematology Domain

## Introduction

This domain applies Domain-Driven Design (DDD) to hematology systems. Hematology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood, blood-forming organs, and blood proteins. By applying DDD principles, we create a comprehensive model that captures the complexity of hematology practice across its major clinical and laboratory subspecialties.

The hematology domain encompasses blood cell disorders, coagulation management, hematologic malignancies, transfusion medicine, bone marrow transplantation, and laboratory hematology. Each of these areas operates as a distinct bounded context with its own models, terminology, and workflows, while sharing common domain concepts through well-defined integration patterns.

## Bounded Contexts

The hematology domain is decomposed into six bounded contexts, each reflecting a major area of hematology practice:

1. **Blood Cell Disorders Context** - Anemia classification and management (iron deficiency, megaloblastic, hemolytic, aplastic), hemoglobinopathy evaluation (sickle cell disease, thalassemia), white blood cell disorders (neutropenia, eosinophilia), and platelet disorders (thrombocytopenia, thrombocytosis). This context manages the diagnostic workup and treatment of non-malignant blood cell abnormalities.

2. **Coagulation Management Context** - Bleeding disorder diagnosis (hemophilia, von Willebrand disease), thrombophilia evaluation (Factor V Leiden, antiphospholipid syndrome), anticoagulation therapy management (warfarin, DOACs, heparin), and coagulation factor assay interpretation. This context addresses the balance between hemorrhagic and thrombotic risk.

3. **Hematologic Malignancies Context** - Leukemia classification (ALL, AML, CLL, CML), lymphoma staging (Hodgkin and non-Hodgkin), multiple myeloma management, myeloproliferative neoplasms (polycythemia vera, essential thrombocythemia, myelofibrosis), and chemotherapy protocol administration. This context manages the diagnosis, staging, treatment, and surveillance of blood cancers.

4. **Transfusion Medicine Context** - ABO/Rh blood typing and antibody screening, crossmatch compatibility testing, blood component selection (packed RBCs, platelets, FFP, cryoprecipitate), transfusion reaction monitoring and reporting, and blood product inventory management. This context ensures safe and appropriate blood product use.

5. **Bone Marrow Transplantation Context** - HLA typing and donor search, donor selection (matched related, matched unrelated, haploidentical), conditioning regimen planning, engraftment monitoring, graft-versus-host disease (GVHD) grading and management, and post-transplant infection surveillance. This context manages the complex multi-phase transplant process.

6. **Laboratory Hematology Context** - Complete blood count with automated differential, peripheral blood smear morphology review, flow cytometry immunophenotyping, coagulation panel testing (PT, aPTT, fibrinogen, D-dimer), bone marrow aspirate and biopsy processing, and cytogenetic/FISH analysis. This context provides the diagnostic data foundation for all clinical hematology decisions.

## Strategic Design

The hematology domain uses strategic DDD patterns to manage complexity:

- **Subdomains** classify areas by strategic importance: hematologic malignancies and coagulation management as core subdomains; transfusion medicine and blood cell disorders as supporting subdomains; scheduling and billing as generic subdomains.
- **Context Map** defines the relationships between bounded contexts, including upstream/downstream dependencies and integration patterns such as published language for laboratory result exchange.
- **Anti-Corruption Layers** protect bounded contexts from external systems such as electronic health records, laboratory information systems, blood bank management software, and national donor registries.

## Tactical Design

Within each bounded context, tactical DDD patterns structure the business logic:

- **Aggregates** enforce consistency boundaries around related hematologic concepts such as a transfusion order with its compatibility testing and administration record.
- **Entities** represent domain objects with unique identity, such as patients, blood products, treatment protocols, transplant donors, and laboratory specimens.
- **Value Objects** capture immutable measurements, classifications, and scores such as CBC parameters, coagulation results, WHO disease classifications, and Ann Arbor staging.
- **Domain Events** signal clinically significant occurrences such as TransfusionReactionReported, MalignancyDiagnosed, EngraftmentConfirmed, and CriticalLabValueDetected.
- **Repositories** abstract the persistence of aggregate roots including patient hematologic profiles, blood bank inventories, and treatment protocol catalogs.
- **Domain Services** encapsulate operations spanning multiple aggregates, such as antibody identification panel resolution or chemotherapy dose adjustment calculations.

## References

- Evans, Eric. *Domain-Driven Design: Tackling Complexity in the Heart of Software*. Addison-Wesley, 2003.
- Vernon, Vaughn. *Implementing Domain-Driven Design*. Addison-Wesley, 2013.
- Khononov, Vlad. *Learning Domain-Driven Design*. O'Reilly Media, 2021.
- Hoffbrand, A. Victor, and Paul A.H. Moss. *Hoffbrand's Essential Haematology*. Wiley-Blackwell, 2019.
- Greer, John P., et al. *Wintrobe's Clinical Hematology*. Wolters Kluwer, 2018.
- Fung, Mark K., et al. *AABB Technical Manual*. AABB Press, 2020.
